2640-P: Role of Diabetes Subtypes for Reducing Modifiable Cardiovascular Risk Factors after Bariatric Surgery
Oana Patricia Zaharia, SABINE KAHL, Jennifer Pützer(Hochschule Düsseldorf University of Applied Sciences), Christian Binsch, Frank A. Granderath(Hochschule Düsseldorf University of Applied Sciences), Georgia Xourafa, SANDRA TRENKAMP, PATRICK SCHRAUWEN, Matthias Schlensak(Hochschule Düsseldorf University of Applied Sciences), MICHAEL RODEN, Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.)
Cited by 0
Related Papers
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
|Metabolism|2024|137
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
|Proceedings of the National Academy of Sciences|2025|33
Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
|Diabetes|2023|11
Association of thyroid function with non‐alcoholic fatty liver disease in recent‐onset diabetes
|Liver International|2023|8
PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes
|Clinical Nutrition|2025|4